User profiles for K. Furie
 | Karen FurieProfessor of Neurology, Warren Alpert Medical School of Brown University Verified email at brown.edu Cited by 83807 |
Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Each year, the American Heart Association, in conjunction with the Centers for Disease Control
and Prevention, the National Institutes of Health, and other government agencies, brings …
and Prevention, the National Institutes of Health, and other government agencies, brings …
Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Each year the American Heart Association, in conjunction with the Centers for Disease Control
and Prevention, the National Institutes of Health, and other government agencies, brings …
and Prevention, the National Institutes of Health, and other government agencies, brings …
Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
The American Heart Association (AHA) works with the Centers for Disease Control and
Prevention’s National Center for Health Statistics (CDC/NCHS); the National Heart, Lung, and …
Prevention’s National Center for Health Statistics (CDC/NCHS); the National Heart, Lung, and …
Heart disease and stroke statistics—2010 update: a report from the American Heart Association
…, E Ford, K Furie, C Gillespie, A Go, K Greenlund… - Circulation, 2010 - Am Heart Assoc
Each year, the American Heart Association, in conjunction with the Centers for Disease Control
and Prevention, the National Institutes of Health, and other government agencies, brings …
and Prevention, the National Institutes of Health, and other government agencies, brings …
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of …
…, PT Ellinor, MD Ezekowitz, ME Field, KL Furie… - Circulation, 2019 - Am Heart Assoc
… Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention)
is an ongoing trial evaluating edoxaban treatment versus vitamin K antagonist treatment …
is an ongoing trial evaluating edoxaban treatment versus vitamin K antagonist treatment …
Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
All statistics are for the most recent year available. Prevalence, mortality and hospitalizations
are computed for 2003 unless otherwise noted. Mortality as an underlying or contributing …
are computed for 2003 unless otherwise noted. Mortality as an underlying or contributing …
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart …
The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …
recommendations on the prevention of future stroke among survivors of ischemic stroke or …
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association …
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart …
The aim of this new statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …
[HTML][HTML] A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Background Despite the use of antiplatelet agents, usually aspirin, in patients who have had
an ischemic stroke, there is still a substantial rate of recurrence. Therefore, we investigated …
an ischemic stroke, there is still a substantial rate of recurrence. Therefore, we investigated …